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Abstract:	 Faced with the combined pressures of economic recession and 
growing healthcare costs, public health administrators recognize 
the value of using economic arguments to justify public health 
interventions. Given the expense and the time involved in con-
ducting new economic evaluations, decision-makers regularly 
speculate on the possibility of using results from studies done in 
a different context. This article analyzes the potential for using 
the results of economic evaluations of public health interventions 
in contexts other than those in which the studies were done. 
More specifically, it sheds light on issues of quality and transfer-
ability of analyses for public health decision-making and offers 
practical proposals for increasing the transferability of studies.
Résumé : Face au double fardeau de la récession économique et de la crois-
sance continue des dépenses de santé, les directeurs de santé 
publique perçoivent l’intérêt d’introduire des argumentaires 
de nature économique pour soutenir les interventions de santé 
publique. Conscients que la réalisation de nouvelles études éco-
nomiques est longue et coûteuse, les décideurs s’interrogent 
régulièrement sur la possibilité d’utiliser les résultats d’études 
réalisées dans un autre contexte pour justifier la rentabilité de 
l’intervention. Le présent article analyse le potentiel d’utilisa-
tion des résultats d’évaluation économique des interventions de 
santé publique dans un autre contexte que celui de réalisation 
de l’étude. Il apporte spécifiquement un éclairage sur la qua-
lité et la transférabilité des évaluations économiques pour la 
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prise de décision en santé publique. Il formule en fin de compte 
des propositions pratiques pour accroître la transférabilité des 
études. 
INTRODUCTION
Faced with the combined pressures of economic recession 
and growing healthcare costs, public health administrators recognize 
the value of using economic arguments to justify public health in-
terventions. Economic evaluation consists of identifying, measuring, 
valuing, and comparing the costs and consequences of two or more 
alternative programs or interventions. In the health field, economic 
evaluations are used to analyze how efficiently resources have been 
allocated and how resources should be allocated to maximize well-
being. In public health, economic evaluation takes into account the 
amount of resources used by an intervention and the corresponding 
level of health-related outcomes (Centers for Disease Control and 
Prevention [CDC], 2013; Drummond, Stoddart and Torrance, 1987). 
Depending on whether the consequences are expressed as monetary, 
physical, or qualitative variables, the analysis may be cost-benefit, 
cost-effectiveness, or cost-utility analysis respectively (l’Institut na-
tional d’excellence en santé et en services sociaux [INESSS], 2013). 
Thus, economic evaluations provide data on an intervention’s effi-
ciency or profitability (Drummond et al., 1987) and appear relevant 
to guide decision-making in public health (Ball et al., 2009; Gold-
smith, Hutchison, & Hurley, 2004). 
However, to date economic evaluations in healthcare have focused 
mainly on drugs and technologies, as well as on interventions with 
determinate effects such as preventive clinical practice intervention. 
They have focused less on public health interventions that prevent 
the emergence of health problems through health promotion and 
prevention practices and the development of health-promoting public 
policies (Goldsmith et al., 2004). Goldsmith et al. pointed out that 
even when such evaluations exist, they generally are concerned with 
interventions related to preventive clinical practice.
Several problems have emerged in economic evaluations of public 
health interventions, and some have been highlighted in the litera-
ture (Drummond, Weatherly, & Ferguson, 2008; Shiell, Hawe, & Gold, 
2008; Weatherly et al., 2009). First, there is the complexity of public 
health interventions. These are not simple; rather, they comprise a 
number of actions and programs with a common orientation, each 
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with its own costs and funding, leading to widespread and long-term 
effects with complex causalities. Developing a complete and accurate 
description of all activities related to a public health policy as well as 
their sources of funding represents a challenge in itself.
Second, there is the difficulty of attributing the effects of multi-
component interventions. Public health interventions often involve 
multiple actors using many media and producing a wide spectrum 
of impacts. Compiling all the elements (costs, activities, effects) and 
identifying causal relations between the intervention and the chain 
of effects is complex (Shiell et al., 2008). This difficulty affects the 
understanding of intervention and the attribution of economic ben-
efits, reinforcing the importance of thinking about new or adaptive 
approaches to conducting economic evaluations in public health.
Third, there is the difficulty of choosing the analysis perspective. Tra-
ditional economic evaluations recommend that the analyst choose a 
particular analysis perspective (for example, that of the hospital, the 
insurer, the patient, etc.). This has been criticized by Drummond et 
al. (2008), who recommend broadening the analysis perspective to 
include all costs and benefits for all stakeholders, although this idea 
has not been integrated into methodological guidelines. Because pub-
lic health interventions often have an impact on various spheres—
health, education, employment, health inequalities, early childhood 
development, and so on—the logic of adopting a single perspective is 
untenable. Can we justify conducting the economic evaluation of an 
intervention that has a wide spectrum of impacts while considering 
only the cost borne by one type of payer?
Finally, there is the problem of the delay between actions and effects. 
The time horizon is a major concern when assessing an intervention’s 
effect. Public health interventions are rarely effective in the short 
term, making it difficult to distinguish effects attributable to the 
intervention from those due to environmental changes. Over a long 
period, many changes occur: diseases evolve, demographics change, 
as do environmental risk factors. These changes affect causal rela-
tions between the intervention and its impacts, as well as our capac-
ity, as researchers, to formulate realistic hypotheses for attributing 
changes to causes.
In a difficult economic context, decision-makers in public health 
want to know how efficiently resources have been allocated and how 
resources should be allocated to maximize well-being. Because eco-
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nomic evaluations are often costly and time-consuming (Goeree et al., 
2007), decision-makers are increasingly interested in the possibility 
of using results from studies done in contexts outside of their own 
(Clément, Barnay, & LePen, 2011; Haute Autorité de Santé, 2011). 
Quebec’s public health decision-makers are no exception. They have 
expressed both the intention and the need to analyze the quality and 
transferability of economic evaluations carried out in other contexts 
to develop arguments to defend similar public interventions in the 
Quebec context. It was from this standpoint that, in partnership 
with Quebec’s Ministry of Health and Social Services (MSSS) and its 
Public Health Directorate, this study was developed.
The main objective of this study was to assess the potential for us-
ing the results of economic evaluation studies in contexts other than 
those in which they were conducted. For such potential to be viable, 
users should be able to have confidence in the results obtained (qual-
ity) with few biases and also to extrapolate the results to other imple-
mentation contexts (transferability). More specifically, our aim was to 
shed light on the quality and transferability of economic evaluations 
for purposes of public health decision-making.
This article presents (a) the results of our analysis of the quality and 
transferability of economic evaluations of public health interventions 
and (b) some suggestions to increase the transferability of economic 
evaluations: focus more on the logic model to describe the complex-
ity of interventions, take into account all the elements that affected 
the results in the other implementation context, and use sensitivity 
analysis to define the real value of costs and benefits.
The results of this study will be useful not only for the scientific 
community working in public health economic evaluation, but also 
for public health decision-makers seeking to make the case for the 
economic value of their programs without having to carry out more 
primary studies in their own contexts.
METHODS
Research Strategy
For this study we analyzed in depth the quality and transferability of 
four economic evaluation studies that included an estimate of return 
on investment (dollars gained or cost savings for every dollar invest-
ed in the intervention; INESSS, 2013). These studies were a kind of 
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cost-benefit analysis demonstrating economic benefits that exceeded 
costs. These evaluations were identified and selected by the public 
health directors of the MSSS. They dealt with two themes of interest 
for public health in Quebec: early childhood care and education, and 
the prevention of nosocomial infections in hospitals. The four studies, 
two on each theme, were cost-benefit analyses conducted in different 
contexts in the United States and Canada: (a) the High/Scope Perry 
Preschool Project implemented in Michigan, in the US (Schweinhart, 
1994, 2003; Schweinhart et al., 2010; Schweinhart et al., 2005); (b) 
the Early Childhood Education and Care (ECEC) program developed 
in Ontario, in Canada (Cleveland and Krashinsky, 1998, 2002, 2003, 
2004; Iglesias and Shalala, 2002; McCain and Mustard 2002; Ontario 
Prevention Clearinghouse, 2006); (c) a program to prevent nosoco-
mial respiratory infections in a pediatric hospital in Philadelphia, 
in the US (Macartney, Gorelick, Manning, Hodinka, and Bell, 2000); 
and (d) the program for nosocomial infection prevention in Quebec 
hospitals (Comité sur les infections nosocomiales du Québec [CINQ], 
2004; Institut national de santé publique du Québec [INSPQ], 2008; 
MSSS 2004, 2006a, 2006b, 2011).
Descriptions of the Studies
Economic evaluation of the High/Scope Perry Preschool Project
The study by Schweinhart et al. (2005) analyzed in this article eval-
uated the outcomes and cost-effectiveness of the High/Scope Perry 
Preschool Project. This was an early childhood education and devel-
opment program implemented in Ypsilanti, Michigan, USA, between 
1962 and 1967. The High/Scope Perry Preschool Project was based 
on the philosophical premise that attention to early childhood de-
velopment would have positive repercussions for those children’s fu-
tures in terms of health and well-being, education, greater economic 
productivity, social inclusion, crime prevention, and so on. Forms of 
this program are currently in operation in several countries world-
wide.
This study followed a group of 123 children with low intelligence 
quotients (IQ) from disadvantaged families, beginning at the age of 
three years. They were randomly distributed into an experimental 
group (58 children) and a control group (65 children). Data were col-
lected annually from ages 3 to 11 years, then again at ages 14, 15, 
19, 27, and 40 years; hence the study extended over a 37-year period. 
The most recent publication by Schweinhart et al. (2005), which is 
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the eighth monograph in the series on the economic evaluation of 
the High/Scope Perry Preschool Project, reports the results for those 
children at age 40. The main sources of data used in that study were 
(a) analyses of administrative data: public and private school fees 
(primary, secondary, and special schools) in the state of Michigan; 
teachers’ salaries; costs related to arrests, charges, incarcerations, 
prison; and amount of taxes; and (b) family surveys to document 
parents’ occupations (employment) over the previous five years; their 
level of education; and the structure of the household residence 
(number of rooms).
This study demonstrated the effectiveness of the High/Scope Perry 
Preschool Project in terms of income, employment, social inclusion, 
and crime reduction. It also showed that the High/Scope Perry Pre-
school was cost-effective (return on investment) for society, in that 
every dollar invested in this early childhood care and education 
project generated a return of more than $16, with a total benefit 
per participant of around $244,812 (USD) (Schweinhart et al., 2005; 
Heckman, Moon, Pinto, Savelyev, and Yavitz, 2009, 2010). 
Economic evaluation of the Early Childhood Education and Care 
program
The study by Cleveland and Krashinsky (2003) analyzed here, 
based on their earlier study in 1998, assessed the costs and benefits 
of the Early Childhood Education and Care program implemented 
in Ontario, Canada. The aim of that program is to create an envi-
ronment that is conducive to the well-being and full development 
of young children (0 to 5 years old). Its main strategies are to cre-
ate high-quality day care, set up an early childhood learning and 
education program, develop prenatal care and services, support new 
parents, and create recreation programs to support children’s full 
development (constructing parks, gyms, etc.). The ultimate goals 
of this program are to improve the future physical health of young 
children (obesity, diabetes, hypertension, coronary disease); to in-
crease their level of education (IQ levels, academic levels); to facili-
tate their entry into the workforce; and to develop healthy attitudes 
and behaviours (reductions in violence, alcoholism, smoking, social 
stress, etc.).
The study by Cleveland and Krashinsky (2003) was based on major 
surveys conducted in Canada: Statistics Canada’s 1996 Labour Force 
Survey (to document mothers’ employment), Cycle 1 of the National 
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Longitudinal Survey of Children and Youth, 1994–95, and the Ca-
nadian National Child Care Survey (data on day care services). It 
dealt only with children ages 2 to 5 years. Thus, 1.3 million women 
with at least one child between those ages and 1.6 million children 
(approximately 400,000 children for each age year) were studied. 
The only benefits calculated were those related to educational gains 
for children (school performance at age 10, etc.) and to the mother’s 
employment status. Other benefits (health, attitude and behaviour, 
etc.) were not measured. The dollar valuations of these benefits were 
based on two hypotheses: that the change in the mother’s employ-
ment status was not related to the mother’s age or number of chil-
dren, but to the program; and that the benefit per child was $3,600, 
dropping to $1,800 if the child was placed in a day care centre thanks 
to the program. The study demonstrated a return on investment for 
the program, in 2002, of $2 per dollar invested, resulting in a total 
benefit of $10,548,000 per year.
Economic evaluation of a nosocomial infection prevention program 
in a pediatric hospital
The study by Macartney et al. (2000) analyzed here evaluated the 
cost-effectiveness of a nosocomial infection prevention program im-
plemented in a 304-bed pediatric hospital in Philadelphia, Penn-
sylvania, USA. The aim of this program was not only to reduce the 
incidence of nosocomial respiratory infections (RSV-NI) in hospi-
talized children, but also to educate medical personnel on how to 
act before, during, and after an infection outbreak. It thus helped 
strengthen epidemiological control, monitoring, and surveillance in 
the hospital. The program was based on a hygiene and cleanliness 
awareness program and staff training.
From an institutional standpoint, the study by Macartney et al. 
(2000) evaluated the cost-benefit of the program by comparing the 
situations (incidence of RSV-NI: number of cases detected per 1,000 
patient days) before and after the program’s implementation in the 
hospital. Data were collected over eight periods (four pre-implemen-
tation, 1988–1989; and four post-implementation, 1995–1996). The 
survey looked at 148 at-risk hospitalized patients: 88 before the in-
tervention and 60 after it. The costs of a hospital stay in 1996, in 2000 
dollars, were used to value the hospital treatment of these infections. 
The benefits were valued by comparing the costs associated with 
treatment or care of 30 pre-intervention and 30 post-intervention 
cases, all of which were randomly selected. Only benefits directly 
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related to the treatment of RSV-NI were valued. The program’s cost-
benefit was calculated, in 2000, to be $6 per dollar invested, with a 
benefit of $9,419 per case detected.
Economic evaluation of Quebec’s nosocomial infection control 
program 
A study carried out in 2010 by the Comité sur les Infections Noso-
comiales du Québec (CINQ; MSSS and INSPQ, 2010) analyzed the 
benefits of a nosocomial infection prevention program implemented 
in 91 general and specialized hospitals in Quebec. The aim of that 
program was to reduce the incidence of nosocomial infections (C. 
difficile, methicillin-resistant Staphylococcus aureus [MRSA], and 
others) in health facilities. The program was based on (a) develop-
ing programs of nosocomial infection prevention and control (PCI), 
including nosocomial infection surveillance and vigilance regarding 
emergent problems related to infections; policies, procedures, and 
support measures; education and training; assessment; communica-
tion and information; and outbreak management; and (b) implement-
ing programs for managers and all health facilities staff to raise 
awareness about hygiene and cleanliness in these hospitals.
Based on epidemiological surveillance data from 2004 to 2009, the 
CINQ demonstrated a reduction of nearly 50% in the incidence of 
C. difficile. More than 3,000 C. difficile infections per year had been 
prevented, including more than 100 deaths. Nearly $42 million was 
saved (based on an estimated cost of $14,000 CDN for treatment of 
a patient with C. difficile). In addition, the CINQ highlighted a 40% 
reduction in nosocomial MRSA bacteremias, such that more than 
250 MRSA bacteremias, more than 2,000 MRSA infections, and more 
than 100 deaths had been prevented annually. This resulted in sav-
ings of more than $40 million CDN. In the end, this program also 
freed up an average of 360 beds per year. 
The Quality of the Studies
The quality of a study is defined as its capacity to analyze a phe-
nomenon using rigorous methods to provide valid estimates with 
few errors (Contandriopoulos, Champagne, Potvin, Denis, & Boyle, 
2005). Analyzing the quality of studies therefore involves assessing 
whether the study has taken into account all the questions consid-
ered to be essential, so that the estimates obtained are valid (internal 
validity; Clément et al., 2011; Haute Autorité de Santé, 2011). In the 
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present study, we used the checklist for assessing economic evalu-
ations developed by Drummond, Sculpher, Torrance, O’Brien, and 
Stoddart (2005) to assess the quality of the studies. This checklist is 
based on 10 criteria presented in Table 1.
The two authors of this article separately assessed the quality of the 
four studies and then discussed the results together. By consensus, 
the studies were classified according to whether their quality was 
high (+ +), medium (+ -), or low (- -) for all the criteria. A delibera-
tive process was used to justify each assessment and to ensure the 
cogency of each judgement.
The Transferability of the Studies’ Results
Transferability of results is defined as the potential for using the 
results obtained in one study in other contexts, which may be similar 
or different (Brousselle, Lachaine, & Contandriopoulos, 2009). Thus, 
a transferable study is one that has strong external validity; in other 
words, its results—and even its methods—have the capacity to be 
generalized to other contexts, other situations, other times, and other 
populations (Clément et al., 2011; Haute Autorité de Santé, 2011). 
While transferability is often confused with the notion of generaliz-
ability, the latter also includes the notion of extending the results 
obtained to other units of a target population (extrapolation or infer-
ence) (Rosner, 2010).
We analyzed the studies’ transferability by identifying in each study 
the elements that made them more easily transferable to other con-
texts. These elements were similar to those identified by Urdhal, 
Manca, and Sculpher (2006) in their study assessing the variability 
and generalizability of published economic evaluation results related 
to osteoporosis (Clément et al., 2011). They highlighted, among oth-
ers, the following elements: 
1. a clear description of the users and decision-makers who 
are the probable end-users of the results of the study being 
analyzed; 
2. the transparency of the intervention model studied, which 
clearly describes the research question, the structure, the 
data considered, and especially the methods used;
3. the relevance of the data for the decision-maker, by clearly 
identifying all the sources of data used, the units of analysis, 
the time horizon, and the relevance of the comparator used;
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4. the use of sensitivity analyses to vary the different data and 
study the different values that might be observed within one 
jurisdiction or another.
As with quality, both authors of the present article analyzed each 
study for transferability. Working separately, we identified the 
strengths and weakness of each study in relation to the above ele-
ments. After discussion we reached consensus and attributed high 
(+ +), medium (+ -), or low (- -) scores for transferability to each of 
the four studies.
RESULTS
Based on a high level of agreement between the two authors with 
respect to the quality and transferability of the studies analyzed, the 
following results emerged.
Result 1: The Quality of the Studies
The analysis of the data showed that the four studies satisfied nearly 
all of the criteria set out by Drummond et al. (2005) with respect to 
quality. Table 1 summarizes the results of the analysis. 
Ensuring the quality of the studies is the first condition, but is not 
sufficient to support using the results for another jurisdictions. The 
transferability of results must also be shown.
Result 2: Transferability of Studies
The analysis of the data also showed that three of the four studies 
performed less well in terms of Urdhal et al.’s (2006) four criteria. 
Table 1 also summarizes the results of the analysis of the transfer-
ability of each of the studies by showing only the final score for 
transferability.
Economic evaluation of the High/Scope Perry Preschool Project (- -)
The transferability analysis of this study showed that a number 
of precautions would need to be taken before the results could be 
applied to other contexts or to similar contexts. The study was con-
ducted on children three years of age who were from poor families 
and had low IQs. The results could therefore only be transferred to 
children in this age category. The effects were converted into dollars 
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using school fees, salaries, crime prevention costs, taxes, and so on. 
All these factors are a function of the study’s particular context and 
setting (Michigan). The same is true for the total costs of funding 
invested in the program. 
Economic evaluation of the Early Childhood Education and Care 
program (- -)
The transferability analysis showed that it would be important to 
take certain precautions before transferring the results of this study. 
Since the study involved children ages 2 to 5 years, the results can 
only be generalized to this age group. As in the first study, the costs 
associated with the program are a function of the intervention’s con-
text and setting in Ontario.
Economic evaluation of a nosocomial infection prevention program 
in a pediatric hospital (- -)
The transferability analysis of the economic evaluation results of this 
program showed a low level of applicability to other contexts, since it 
was conducted only in one hospital and, especially, there is nothing 
to indicate this hospital is representative of other hospitals in the 
Philadelphia region. Finally, the cost of the program and the valu-
ation of the benefits are a function of the hospital and of the costs, 
such as salaries, prevailing in the region of Philadelphia. The only 
potentially transferable elements would be the methods of valuing 
costs and consequences.
Economic evaluation of Quebec’s nosocomial infection control 
program (+ -)
The transferability analysis showed potential for transferring the 
methodology for valuing the effects of this program to other contexts, 
since the study was carried out in many (91) hospitals, represent-
ing a variety of situations. However, the costs of treating a patient 
with a nosocomial infection are contextualized to Quebec, and this 
amount of $14,000 CDN could not, or could not easily, be applied to 
other contexts.
DISCUSSION
This article was developed in partnership with decision-makers to 
respond to their need to use published scientific information on eco-
nomic evaluation of public health interventions and programs. Its 
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main objective was to evaluate the potential for using the results 
of cost-benefit studies in other contexts than those in which they 
were carried out. More specifically, it was intended to shed light on 
the quality and transferability of cost-benefit analyses for use in 
decision-making in public health.
In-depth analysis of four studies selected by decision-makers on 
two themes of interest to them (early childhood care and education, 
and prevention of nosocomial infections in hospitals), which showed 
economic benefits that exceeded their costs and were carried out in 
different contexts, found that the studies were of high quality but 
that their results were not readily transferable to other contexts.
The numbers in these studies demonstrate sufficiently substantial 
economic advantages to make it safe to venture the opinion that such 
interventions could be equally advantageous in other contexts. How-
ever, using the return-on-investment amounts as presented would 
be a mistake, since monetary values (for example, school costs) vary 
enormously from one context to another.
From this reading of the results, we can draw lessons related to using 
the results of economic evaluations and offer proposals for conduct-
ing and publishing economic evaluations. 
Facilitate the Comparison of Interventions
Observations: In this exercise, which consisted of analyzing existing 
studies with an eye toward implementing a new intervention, a key 
question was the extent to which the interventions were compara-
ble. The approach we used here clearly illustrated this aspect. The 
decision-makers wanted to analyze the results of studies published 
for two types of programs: early childhood care and education and 
prevention of nosocomial infections in hospitals. The first issue we 
explored was the nature of the intervention: to what extent were the 
interventions in the studies we analyzed comparable to each other? 
How similar were they to the model that the decision-makers were 
contemplating implementing? This is not a trivial question, and 
differs from the analysis of quality and transferability. It refers to 
the constituent elements of the intervention itself and to the causal 
process that will be operating to achieve the targeted objectives. Cur-
rently, very few economic evaluations present detailed descriptions 
of the intervention or these action processes. Like most economic 
evaluations in the literature, none of these studies did so.
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Proposal: In the field of evaluation, which is developing very much in 
lockstep with economic evaluation (because the latter belongs to the 
field of evaluation), it is strongly recommended that a logic model of 
the intervention be created as a first step (Brousselle & Champagne, 
2011; Funnell & Rogers, 2011; Knowlton & Phillips, 2009; Rossi, 
Lipsey, & Freeman, 2004; Weiss, 1998). The logic model differs from 
a decision tree (generally used in economic evaluations), in that it 
presents the components of the intervention—resources, activities, 
and effects (proximal, intermediate, and distal)—as well as the links 
between these various components. A decision tree is a part, or an 
incomplete form, of a logic model. It presents only the causal chain 
of effects and is generally used to analyze the effects of clinical in-
terventions.
Such an approach would be useful as a precursor to economic evalu-
ation. This exercise would make it easier to assess the quality of 
studies, and particularly to evaluate whether all the effects were 
properly incorporated into the study, or to analyze more easily the 
impact of considering the partial effects of an intervention. Building 
a logic model is especially relevant for interventions whose effects 
are not clearly delineated and are spread over time, as is often the 
case in public health interventions. The presence of a logic model 
of the intervention in published economic evaluation studies would 
definitely be helpful in analyzing the extent to which an interven-
tion being contemplated is similar to interventions analyzed in the 
literature, which would allow for a more accurate interpretation of 
the results of the published results.
Maximize the Transferability of Studies
Observations: In the four studies, our analysis showed low potential 
for transferability to other jurisdictions. The key question in this 
matter is to know to what extent the factors related to the study’s 
context affected the cost-efficiency or cost-benefit ratios obtained 
(Willke, Glick, Polsky, & Schulman, 1998). Several authors have ad-
dressed this question in economic evaluation (Clément et al., 2011). 
Willke et al. (1998) identified certain factors that could influence the 
results and efficiency of interventions in other contexts: differences 
in terms of population characteristics, epidemiological factors, and 
the costs of the intervention. Likewise, O’Brien (1997) highlighted 
other differences that could diminish the transferability of studies, 
that is, differences related to demographics, epidemiology, clinical 
practices, incentives, relative prices, and opportunity costs. Goeree 
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et al. (2007), in a literature review, compiled a list of factors affect-
ing the transferability of economic evaluation studies and the use 
of their results: (a) the demographic characteristics of patients (age 
and sex, level of education, socioeconomic status, risk factors, medi-
cal history, genetic factors, environmental factors, life expectancy, 
income, type of insurance, etc.); (b) patients’ attitudes toward treat-
ment, their compliance, the disincentives they may face (copayments, 
deductibles, etc.), and the characteristics of the disease being stud-
ied (epidemiology, case-mix, severity of illness, comorbidity); (c) the 
characteristics of the health professionals (clinical practices, type of 
remuneration, incentives, regulatory mechanisms; Clément et al., 
2011; O’Brien, 1997); (d) the characteristics of the healthcare sys-
tem (resources available, level of technology and innovation, other 
available treatments, wait lists, availability of generic drugs or sub-
stitutes, etc.); and (e) methodological criteria (costs considered, per-
spective of the study, temporal horizon, discounting rate, opportunity 
costs). Barbieri et al. (2005) point out that another major source of 
divergence is to be found in the type of study carried out, and that the 
range of variability depends on the analytical decisions taken by the 
researcher. Two types of factors appear to play a role in determining 
whether results will be transferable to contexts other than those in 
which studies were carried out: factors related to context and those 
related to analytical decisions, which are a function of researchers’ 
subjectivity and experience. Even though we know very little about 
the contextual characteristics within which these studies were car-
ried out, it is possible, as Chen, Donaldson, and Mark (2011) have 
noted, for researchers to have an impact on the studies’ potential for 
transferability.
Proposals: First, researchers and evaluators should recount the study 
as transparently as possible. As affirmed by the Haute Autorité de 
Santé (2011), the key criterion for improving transferability is trans-
parency. In effect, it is important (a) to provide as much information 
as possible on the data, presenting them clearly and including their 
sources, the origins of the prices and quantities used, the currency, 
the model used, and so on; (b) to present clearly the comparators 
used; (c) to identify clearly the different costs and quantities used; (d) 
to specify the study’s perspective and horizon; (e) to present sensitiv-
ity analyses when necessary, as they help increase the variability of 
the results; and (f) when certain information cannot be included in 
the presentation of the study, to indicate to the reader how it may 
be obtained. This proposal is, however, the same as that for foster-
ing the evaluation of study quality (Drummond et al., 2005), which 
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may explain why certain authors have noted an apparent correla-
tion between methodological quality and transferability of studies 
(Boulenger et al., 2005; Clément et al., 2011; Knies, Ament, Evers, 
& Severens, 2009). Our experience has shown that transparency is 
a necessary but insufficient condition for analyzing whether results 
can be applicable to another implementation context.
Second, factors related to transferability should be meticulously doc-
umented and analyzed. Although quality criteria for economic evalu-
ations are well established in the literature in the form of guidelines 
(Drummond et al., 2005), no guidelines have yet been defined to 
facilitate studies’ transferability, except in disparate articles in the 
literature that have not been integrated. Welte, Feenstra, Jager, and 
Leidl (2004) have developed a model to identify factors that could in-
fluence the transferability of cost-effectiveness studies. These factors 
include the methodological characteristics of the study, the features 
of the healthcare system in which the study is conducted, the char-
acteristics of the target population, elements influencing the efficacy 
of the intervention being studied, and a description of the economic 
context in which the study was done (currency, productivity, econo-
mies of scale, employment, etc.), not to mention the presentation of 
other contextual elements related to the intervention. Systematic 
reflection by the researchers carrying out the study can help target 
the factors that, in their view, would be most likely to influence the 
results in different implementation contexts. Another option would 
be to introduce sensitivity analyses, not on uncertainty factors identi-
fied during the study, as is currently done, but rather on contextual 
characteristics, in order to test the robustness of the results when 
characteristics of the context are changed.
Summary Proposal
All researchers involved in performing economic evaluations should 
be concerned with the issue of transferability of their research re-
sults to maximize their utilization and potential impact. Just as 
guidelines for evaluating the quality of economic evaluations have, 
to a certain extent, helped standardize the conduct and presenta-
tion of economic evaluations, it would be helpful to have a frame-
work to guide the conduct and presentation of studies that would 
promote the use of economic evaluation results in contexts other 
than those in which the studies were conducted. Here we propose a 
series of steps and parameters that could foster the transferability 
of economic evaluation results. We have tried to integrate all the 
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points raised in discussions by the different authors consulted. Our 
proposals are:
1. Build and validate the logic model of the intervention. In 
cases where two interventions are compared, both logic mod-
els should be created. The logic model should depict how the 
intervention is operationalized, including clinical practices.
2. Conduct the study in accordance with established qual-
ity criteria (such as those of Drummond et al., 2005). The 
impacts of the researchers’ methodological and analytical 
choices would generally be incorporated and declared at this 
stage.
3. Identify the elements that could affect the results of the 
study. In particular, the following items should be analyzed:
- characteristics of the population being studied and the 
target population;
- characteristics that could affect the effectiveness of the 
intervention: comorbidity, treatment compliance, epide-
miological characteristics, and so on;
- costs of the intervention, in line with the perspective of 
the study;
- characteristics associated with the care provision model 
and the healthcare system.
4. Perform sensitivity analyses to vary certain parameters 
identified as likely to be different in other contexts and that 
could affect the results of the study, in order to test and de-
termine the robustness of the results.
CONCLUSION
Carrying out economic evaluations of public health interventions 
appears to be a long and costly process (Goeree et al., 2007) be-
cause it requires many resources and data are collected on effects 
that manifest over time. In addition, the characteristics of public 
health interventions, especially the fact that a large proportion of 
these interventions have broad-based effects that are spread out over 
time, render economic evaluations difficult because the methodology 
applies primarily to interventions whose effects are circumscribed 
(Drummond et al., 2005). These characteristics intensify the need 
to be able to use existing studies, which are more rare in public 
health than in clinical interventions (Goldsmith et al., 2004), to guide 
decision-making on resource allocation in this sector, as well as to 
guide the implementation of interventions. However, to be able to use 
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existing results, we need to be able to judge the value of their results 
in relation to the planned implementation context. As we have seen 
here, the studies were presented in such a way that we were able to 
assess their quality, which was found to be high overall. The main dif-
ficulty had to do with the assessment of the transferability of results. 
Our objectives were, first, to know to what extent the interventions 
evaluated were comparable to the interventions being envisioned or 
implemented and, second, to understand how the context in which 
the study was carried out affected the results obtained. That analysis 
led us to formulate proposals that could be incorporated into future 
studies to foster transferability of economic evaluation results.
We have focused on public health interventions. This choice was im-
pelled by research opportunities, but also reflects decision-makers’ 
need for existing research data in this frield. The relative scarcity 
of economic evaluations in the field of public health intensifies the 
perceived utility of existing results for guiding decision-making. Rec-
ognition of this need could stimulate an improved economic evalu-
ation practice that would foster transferability of results, just as, a 
few years ago, recommendations for the conduct of economic evalua-
tions helped standardize economic evaluation practice, improved the 
quality of studies, and made them easier for readers to understand 
(Canadian Agency for Drugs and Technologies in Health [CADTH], 
2006; Drummond et al., 2005; National Institute for Clinical Excel-
lence [NICE], 2005). Even though economic evaluation practice is 
not currently oriented toward fostering transferability of results, 
the adjustments needed would require only marginal research ef-
fort, but could potentially have a major impact on the use of research 
results, not only in public health interventions, but in other types of 
interventions as well.
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